Nektar Therapeutics
NKTR
#6041
Rank
โ‚น85.23 B
Marketcap
โ‚น4,190
Share price
6.40%
Change (1 day)
252.71%
Change (1 year)

Earnings for Nektar Therapeutics (NKTR)

Earnings in 2025 (TTM): -โ‚น9.86 Billion

According to Nektar Therapeutics 's latest financial reports the company's current earnings are โ‚น62.6 Million. In 2024 the company made an earning of -โ‚น10.67 Billion, an increase over its 2023 earnings that were of -โ‚น24.73 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nektar Therapeutics from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น9.86 Billion-7.68%
2024 -โ‚น10.67 Billion-56.85%
2023 -โ‚น24.73 Billion-24.31%
2022 -โ‚น32.67 Billion-30.25%
2021 -โ‚น46.84 Billion17.87%
2020 -โ‚น39.74 Billion0.88%
2019 -โ‚น39.39 Billion-164.46%
2018 โ‚น61.11 B-810.61%
2017 -โ‚น8.6 Billion-37.06%
2016 -โ‚น13.67 Billion89.22%
2015 -โ‚น7.23 Billion48.22%
2014 -โ‚น4.88 Billion-65.93%
2013 -โ‚น14.31 Billion-6.81%
2012 -โ‚น15.35 Billion28.95%
2011 -โ‚น11.91 Billion258.8%
2010 -โ‚น3.32 Billion-63.94%
2009 -โ‚น9.2 Billion-392.45%
2008 โ‚น3.14 B-211.74%
2007 -โ‚น2.82 Billion-79.57%
2006 -โ‚น13.78 Billion-16.9%
2005 -โ‚น16.59 Billion81.53%
2004 -โ‚น9.14 Billion54.19%
2003 -โ‚น5.93 Billion-33.87%
2002 -โ‚น8.96 Billion-9.6%
2001 -โ‚น9.91 Billion73.39%
2000 -โ‚น5.72 Billion108.9%
1999 -โ‚น2.74 Billion39.48%
1998 -โ‚น1.97 Billion60.02%
1997 -โ‚น1.23 Billion18.05%
1996 -โ‚น1.04 Billion31.82%
1995 -โ‚น0.79 Billion57.14%
1994 -โ‚น0.51 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
โ‚น737.91 B-7,345.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.060 T-10,516.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น2.066 T-20,393.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
โ‚น13.51 M-100.13%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.171 T-11,604.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
-โ‚น24.17 Billion 137.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
โ‚น36.30 B-456.48%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
โ‚น2.899 T-28,571.74%๐Ÿ‡บ๐Ÿ‡ธ USA